Clinical Trials Directory

Trials / Completed

CompletedNCT05766462

Allometric-Pace Study

Utilization of Personalized Pacing to Improve Quality of Life in Sinus Node Dysfunction Patients

Status
Completed
Phase
Study type
Observational
Enrollment
73 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to improve quality of life in sinus node dysfunction patients by utilizing allometric lower rate pacing (or called personalized lower rate, PLR) in standard commercially available dual-chamber pacemakers. The primary objective is to achieve a significant improvement in patients' quality of life with use of PLR pacing in comparison with the control group with nominal lower rate in patients with implanted dual-chamber pacemaker. The secondary objectives are to assess cardiac functional changes in echocardiography of ventricular mechanical performance with a PLR pacing in comparison with the control group with nominal lower rate, and to assess the viability of using elevated blood pressure as a marker for undetected bradycardia and providing allometric rate to correct bradycardia-related increase in arterial systolic blood pressure.

Conditions

Interventions

TypeNameDescription
OTHERPacemaker lower rate settingPacemaker lower rate is set by physician and may be adjusted according to the physician diagnosis.

Timeline

Start date
2023-03-20
Primary completion
2024-11-04
Completion
2025-01-31
First posted
2023-03-13
Last updated
2025-02-07

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05766462. Inclusion in this directory is not an endorsement.

Allometric-Pace Study (NCT05766462) · Clinical Trials Directory